Association between heparin-binding protein and other clinical indicators with the microscopic severity of Mycoplasma pneumoniae pneumonia

Yu-Rong LI, Cui-Ling Zhang, Yi WU, Ru LIU, Ling-Jian MENG

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 708-714.

PDF(976 KB)
PDF(976 KB)
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 708-714. DOI: 10.7499/j.issn.1008-8830.2511006
CLINICAL RESEARCH

Association between heparin-binding protein and other clinical indicators with the microscopic severity of Mycoplasma pneumoniae pneumonia

Author information +
History +

Abstract

Objective To investigate the correlation between serum heparin-binding protein (HBP) and other clinical indicators with the bronchoscopic lesion severity in children with Mycoplasma pneumoniae pneumonia (MPP), in order to understand their potential value in guiding diagnosis and treatment. Methods A retrospective analysis was conducted on 248 children with acute MPP admitted to the Department of Pediatrics, Affiliated Hospital of Xuzhou Medical University from December 2023 to September 2025. Patients were divided into severe lesion group (n=96) and mild lesion group (n=152) based on bronchoscopic findings. Clinical data including fever peak and duration, serum levels of HBP, C-reactive protein (CRP), D-dimer (DD), lactate dehydrogenase (LDH), and neutrophil percentage (N%) were collected. Statistical analyses were performed between groups, followed by correlation analysis between HBP levels and significant clinical indicators. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of HBP and other indicators for bronchoscopic lesion severity. Results HBP levels in the severe lesion group were significantly higher than those in the mild lesion group (median: 36.2 ng/mL vs 22.8 ng/mL, P<0.001). The severe lesion group also exhibited higher peak fever, longer fever duration, and elevated CRP, DD, and LDH levels (all P<0.05). HBP showed positive correlations with fever duration, CRP, DD, LDH, and N% (rs =0.256, 0.302, 0.635, 0.327, 0.140, respectively; all P<0.05). ROC analysis demonstrated that HBP had the highest area under the curve (AUC=0.850) for predicting bronchoscopic lesion severity, followed by DD (AUC=0.832), CRP (AUC=0.784), LDH (AUC=0.780), fever duration (AUC=0.681), and N% (AUC=0.642). At a cut-off value of 28.9 ng/mL, HBP predicted severe lesions with 80.2% sensitivity and 79.6% specificity. Conclusions Serum HBP, CRP, DD, and LDH are significantly associated with the microscopic severity of bronchoscopic lesions in children with MPP. HBP shows superior predictive performance and may provide valuable clinical guidance for assessing lesion severity.

Key words

Mycoplasma pneumoniae pneumonia / Heparin-binding protein / Inflammatory marker / Bronchoscopy / Severity / Child

Cite this article

Download Citations
Yu-Rong LI , Cui-Ling Zhang , Yi WU , et al . Association between heparin-binding protein and other clinical indicators with the microscopic severity of Mycoplasma pneumoniae pneumonia[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(6): 708-714 https://doi.org/10.7499/j.issn.1008-8830.2511006

References

[1]
de Groot RCA, Estevão SC, Meyer Sauteur PM, et al. Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies[J]. Eur Respir J, 2022, 59(4): 2100129. PMCID: PMC8989055. DOI: 10.1183/13993003.00129-2021 .
[2]
Diaz MH, Hersh AL, Olson J, et al. Mycoplasma pneumoniae infections in hospitalized children: United States, 2018-2024[J]. MMWR Morb Mortal Wkly Rep, 2025, 74(23): 394-400. PMCID: PMC12200605. DOI: 10.15585/mmwr.mm7423a1 .
[3]
Paquette M, Magyar M, Renaud C. Mycoplasma pneumoniae[J]. CMAJ, 2024, 196(32): E1120. PMCID: PMC11444693. DOI: 10.1503/cmaj.240085 .
[4]
Ding L, Jiang Y. Biomarkers associated with the diagnosis and prognosis of Mycoplasma pneumoniae pneumonia in children: a review[J]. Front Cell Infect Microbiol, 2025, 15: 1552144. PMCID: PMC11958718. DOI: 10.3389/fcimb.2025.1552144 .
[5]
Tasouli F, Georgopoulou E, Chatzigrigoriadis C, et al. Heparin binding protein in sepsis: a comprehensive overview of pathophysiology, clinical usage and utility as biomarker[J]. Biomedicines, 2025, 13(9): 2315. PMCID: PMC12467777. DOI: 10.3390/biomedicines13092315 .
[6]
中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 国际流行病学传染病学杂志, 2023, 50(2): 79-85. DOI: 10.3760/cma.j.cn331340-20230217-00023 .
[7]
国家卫生健康委员会人才交流服务中心儿科呼吸内镜诊疗技术专家组, 中国医师协会儿科医师分会内镜专业委员会, 中国医师协会内镜医师分会儿科呼吸内镜专业委员会, 等. 中国儿科可弯曲支气管镜术指南(2018年版)[J]. 中华实用儿科临床杂志, 2018, 33(13): 983-989. DOI: 10.3760/cma.j.issn.2095-428X.2018.13.006 .
[8]
Chen X, Li H, Li J, et al. The potential role of heparin-binding protein in neonatal sepsis: research progress[J]. Front Cell Infect Microbiol, 2024, 14: 1422872. PMCID: PMC11347420. DOI: 10.3389/fcimb.2024.1422872 .
[9]
Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2021, 49(1): e80-e90. DOI: 10.1097/CCM.0000000000004738 .
[10]
Shi M, Wei Y, Huang H, et al. Heparin-binding protein levels as an emerging key biomarker for accurate diagnosis of bacterial meningitis: a promising yet preliminary evaluation[J]. Microb Pathog, 2025, 202: 107417. DOI: 10.1016/j.micpath.2025.107417 .
[11]
Stjärne Aspelund A, Hammarström H, Inghammar M, et al. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients[J]. Am J Transplant, 2018, 18(2): 444-452. PMCID: PMC5813223. DOI: 10.1111/ajt.14458 .
[12]
Ma Z, Wu Q, Yu H, et al. Identification of a heparin-binding protein encoded by Mbov_0510 gene in Mycoplasma bovis [J]. J Bacteriol, 2025, 207(9): e0016025. PMCID: PMC12445077. DOI: 10.1128/jb.00160-25 .
[13]
Liu L, Shao Y, Zhang Y, et al. Neutrophil-derived heparin binding protein triggers vascular leakage and synergizes with myeloperoxidase at the early stage of severe burns (with video)[J]. Burns Trauma, 2021, 9: tkab030. PMCID: PMC8499692. DOI: 10.1093/burnst/tkab030 .
[14]
Sjöbeck M, Sternby H, Herwald H, et al. Heparin-binding protein is significantly increased in acute pancreatitis[J]. BMC Gastroenterol, 2021, 21(1): 337. PMCID: PMC8403433. DOI: 10.1186/s12876-021-01910-6 .
[15]
范江花, 罗海燕, 张新萍, 等. 肝素结合蛋白在重症腺病毒肺炎中的应用[J]. 中华实用儿科临床杂志, 2021, 36(18): 1389-1393. DOI: 10.3760/cma.j.cn101070-20210208-00177 .
[16]
邓俊超, 赵芳丽, 乔莉娜. 肝素结合蛋白对儿童重症感染诊断价值的前瞻性研究[J]. 中国当代儿科杂志, 2022, 24(1): 85-89. DOI: 10.7499/j.issn.1008-8830.2109057 .
[17]
陈真真, 王海青, 刘冬霞, 等. D-二聚体对儿童重症肺炎支原体肺炎合并血栓栓塞诊断价值的双中心研究[J]. 中华实用儿科临床杂志, 2025, 40(8): 609-612. DOI: 10.3760/cma.j.cn101070-20241114-00745 .
[18]
王宽, 蒋瑜, 杨旭峰. 肝素结合蛋白极端升高的临床观察[J]. 中华急诊医学杂志, 2022, 31(9): 1270-1274. DOI: 10.3760/cma.j.issn.1671-0282.2022.09.020 .
[19]
Hovold G, Palmcrantz V, Kahn F, et al. Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis[J]. BMC Pulm Med, 2018, 18(1): 104. PMCID: PMC6011334. DOI: 10.1186/s12890-018-0668-7 .
[20]
Zhang J, Cao Y, Shu W, et al. Neutrophil-derived heparin-binding protein increases endothelial permeability in acute lung injury by promoting TRIM21 and the ubiquitination of P65[J]. Cell Biol Toxicol, 2025, 41(1): 55. PMCID: PMC11882632. DOI: 10.1007/s10565-025-10005-x .
[21]
Meyer Sauteur PM, Beeton ML, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae [J]. Lancet Microbe, 2024, 5(6): e514. DOI: 10.1016/S2666-5247(23)00406-8 .
[22]
Distasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability[J]. Trends Immunol, 2009, 30(11): 547-556. PMCID: PMC2767453. DOI: 10.1016/j.it.2009.07.012 .
[23]
Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability[J]. Nat Med, 2001, 7(10): 1123-1127. DOI: 10.1038/nm1001-1123 .

Footnotes

所有作者均声明无利益冲突。

PDF(976 KB)

Accesses

Citation

Detail

Sections
Recommended

/